Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US sites, creating a rare end-to-end domestic sterile injectable pathway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results